ARS Grand-Est has awarded a €31M inter-ARS evaluation framework for Regional Health Projects to six groupements across two lots

ARS Grand-Est, a body governed by public law operating in the health sector, has awarded an inter-ARS framework agreement for the evaluation of the Regional Health Project of each ARS (Lot 1) and the evaluation of actions, projects or systems implemented within the framework of the Regional Health Project (Lot 2) (Marché interARS - Lot 1 : Evaluation du Projet Régional de Santé de chaque ARS - Lot 2 : Evaluation d'actions, de projets ou de dispositifs mis en œuvre dans le cadre du Projet Régional de Santé) to multiple groupements. The maximum framework value in this notice is €31,000,000.00, covering evaluation consultancy services, with each lot awarded separately. Lot 1 has a maximum value of €6,000,000.00 and Lot 2 has a maximum value of €25,000,000.00. The framework duration is 12 months, with tacit renewal three times for 12 months, up to a maximum total duration of 48 months. The contract was awarded following an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Introduction

ARS Grand-Est, a body governed by public law operating in the health sector, has conducted an open procedure for an inter-ARS framework agreement for the evaluation of the Regional Health Project (PRS) of each ARS and the evaluation of actions, projects or systems implemented within the framework of the PRS. The contract is executed at the scale of the ARS of metropolitan and overseas France, as specified in the DCE. The procurement is divided into two lots: LOT-0001 (Evaluation of the Regional Health Project of each ARS) and LOT-0002 (Evaluation of actions, projects or systems implemented within the framework of the Regional Health Project).

The procurement is not financed with EU funds but is covered by the Government Procurement Agreement (GPA). The award criteria and their weightings are defined in the consultation rules. The framework agreement operates with reopening of competition. The estimated duration is 12 months, with tacit renewal three times for 12 months, up to a maximum total duration of 48 months. Tenders received: 10 for LOT-0001 and 11 for LOT-0002 (submitted electronically). Winners include multiple groupements led by CAPGEMINI CONSULTING, TECHNOPOLIS, PricewaterhouseCoopers Advisory (LOT-0001); and ACSANTIS, Planète Publique, KPMG (LOT-0002). Subcontracting was declared by several winners. Contracts were concluded on 28 September 2026.

Why This Contract Matters

This framework ensures that the ARS have access to a broad panel of qualified evaluation consultancy service providers for the evaluation of their Regional Health Projects and related actions, projects or systems.

This contract matters because it:

• Supports Public Health Evaluation: Provides evaluation of Regional Health Projects and related actions
• Significant Value: €31,000,000.00 maximum framework value in this notice (Lot 1 €6M; Lot 2 €25M)
• Long-Term Commitment: 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• Two Lots: Evaluation of the PRS of each ARS (Lot 1) and evaluation of actions, projects or systems (Lot 2)
• National Coverage: ARS of metropolitan and overseas France
• Competition: 10 tenders (Lot 1); 11 tenders (Lot 2)
• Subcontracting: Declared by several winners

Contract Timeline

• Date winner chosen: 15 September 2026
• Contracts concluded: 28 September 2026
• Initial duration: 12 months
• Maximum renewals: 3 (12 months each)
• Maximum total duration: 48 months
• Notice published: 30 September 2026 (OJ S 189/2026)
• Notice dispatch date: 29 September 2026
• Previous notice: 384813-2026

Contract Overview

ARS Grand-Est conducted an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Key features include:

• Two lots: LOT-0001 and LOT-0002
• Maximum framework value in this notice: €31,000,000.00
• Lot 1 maximum value: €6,000,000.00
• Lot 2 maximum value: €25,000,000.00
• Duration: 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• Framework type: Framework agreement, with reopening of competition
• Evaluation: Cost criteria and weightings defined in the consultation rules
• Winners: Multiple groupements across two lots
• Subcontracting: Yes for several winners (value and percentage unknown)
• No EU funding
• Covered by GPA: Yes

Key Contract Details

• Main classification: 79419000 Evaluation consultancy services
• Place of performance: Meurthe-et-Moselle (FRF31), France; contract executed at the scale of the ARS of metropolitan and overseas France
• Procedure identifier: 95928136-daab-44ff-b1d0-4a732b5e130e
• Internal identifier: 26INT009-AC_evaluationsPRS
• Type of procedure: Open
• Legal basis: Directive 2014/24/EU
• Review body: Tribunal administratif de Nancy
• Review deadline: Référé précontractuel (before contract signature); Référé contractuel (31 days); Recours en contestation de validité (2 months); Recours gracieux (2 months)

Lot Structure

LOT-0001 – Evaluation of the Regional Health Project of Each ARS

• Internal identifier: 1
• Description: Evaluation of the Regional Health Project
• Maximum framework value: €6,000,000.00
• Duration: 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• Winners: Groupement CAPGEMINI x KPMG (led by CAPGEMINI CONSULTING; subcontractor VI SANTE); Groupement TECHNOPOLIS x SEDETIAM x PLURICITE x HIPPOCRATE DEVELOPPEMENT (led by TECHNOPOLIS); Groupement PWC x FORVIS MAZARS (led by PricewaterhouseCoopers Advisory; subcontractors BLUENOVE, GOVHE, Forvis Mazars)
• Tenders received: 10 (submitted electronically)
• Contracts concluded: 28 September 2026
• Subcontracting: Yes for CAPGEMINI and PWC groupements

LOT-0002 – Evaluation of Actions, Projects or Systems Implemented Within the Framework of the Regional Health Project

• Internal identifier: 2
• Description: Evaluation of actions, projects or systems implemented within the framework of the Regional Health Project
• Maximum framework value: €25,000,000.00
• Duration: 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• Winners: Groupement ACSANTIS x SCET x ADOPALE (led by ACSANTIS); Groupement PLANETE PUBLIQUE x Agence PHARE (led by Planète Publique; subcontractor Chaire Santé de Sciences Po); Groupement KPMG x CAPGEMINI (led by KPMG; subcontractor VI SANTE, CAPGEMINI CONSULTING)
• Tenders received: 11 (submitted electronically)
• Contracts concluded: 28 September 2026
• Subcontracting: Yes for PLANETE PUBLIQUE and KPMG groupements

Lot Summary Table

Lot	Title	Max Value (€)	Winner	Tenders
1	Evaluation of the Regional Health Project of Each ARS	6,000,000.00	Groupement CAPGEMINI x KPMG; Groupement TECHNOPOLIS x SEDETIAM x PLURICITE x HIPPOCRATE DEVELOPPEMENT; Groupement PWC x FORVIS MAZARS	10
2	Evaluation of Actions, Projects or Systems Implemented Within the Framework of the Regional Health Project	25,000,000.00	Groupement ACSANTIS x SCET x ADOPALE; Groupement PLANETE PUBLIQUE x Agence PHARE; Groupement KPMG x CAPGEMINI	11
Total		31,000,000.00

Scope of Supply

The framework covers the following services:

• Lot 1: Evaluation of the Regional Health Project of each ARS
• Lot 2: Evaluation of actions, projects or systems implemented within the framework of the Regional Health Project
• Evaluation Consultancy Services: Services under CPV 79419000
• National Coverage: ARS of metropolitan and overseas France

Special Procurement Conditions

• Inter-ARS Framework: The contract is executed at the scale of the ARS of metropolitan and overseas France; details are specified in the DCE
• Framework Agreement: Framework agreement, with reopening of competition
• Renewal: The contract has a firm duration of 12 months; it is tacitly renewable 3 times for 12 months, up to a maximum total duration of 48 months
• Maximum Lot Values: Lot 1 €6,000,000.00; Lot 2 €25,000,000.00
• Award Criteria: The criteria and their weightings are defined in the consultation rules
• Subcontracting: Yes for several winners (value and percentage unknown)
• Electronic Submission: Tenders submitted electronically

About the Contracting Authority

ARS Grand-Est is a body governed by public law operating in the health sector in France.

• Legal type: Body governed by public law
• Activity: Health
• Registration number: 13000783400075
• Location: Nancy, Meurthe-et-Moselle, France (NUTS: FRF31)
• Address: 3 Boulevard Joffre, 54036 Nancy
• Contact point: Unité marchés publics
• Email: Ars-grandest-marches-publics@ars.sante.fr
• Telephone: 0388889323
• Buyer profile: https://www.marches-publics.gouv.fr/entreprise

About the Winning Suppliers

Groupement CAPGEMINI x KPMG – Led by CAPGEMINI CONSULTING (Large, Issy les Moulineaux, FR105); KPMG (Large, Paris, FR101); Subcontractor: VI SANTE (SME, Paris, FR101); Winner of LOT-0001

Groupement TECHNOPOLIS x SEDETIAM x PLURICITE x HIPPOCRATE DEVELOPPEMENT – Led by TECHNOPOLIS (SME, Paris, FR101); SEDETIAM CONSEIL (SME, Lyon, FRK26); PLURICITE (SME, Lyon, FRK26); Hippocrate Développement (SME, Rennes, FRH03); Winner of LOT-0001

Groupement PWC x FORVIS MAZARS – Led by PricewaterhouseCoopers Advisory (Large, Neuilly-sur-Seine, FR105); Forvis Mazars (Large, Levallois-Perret, FR105); Subcontractors: BLUENOVE (SME, Paris, FR101), GOVHE (SME, Paris, FR101); Winner of LOT-0001

Groupement ACSANTIS x SCET x ADOPALE – Led by ACSANTIS (SME, Paris, FR101); SCET - Services Conseil Expertises Territoires (SME, Paris, FR101); ADOPALE (SME, Paris, FR101); Winner of LOT-0002

Groupement PLANETE PUBLIQUE x Agence PHARE – Led by Planète Publique (SME, Paris, FR101); Agence PHARE (SME, Paris, FR101); Subcontractor: Chaire Santé de Sciences Po (SME, Paris, FR101); Winner of LOT-0002

Groupement KPMG x CAPGEMINI – Led by KPMG (Large, Paris, FR101); CAPGEMINI CONSULTING (Large, Issy les Moulineaux, FR105); Subcontractor: VI SANTE (SME, Paris, FR101); Winner of LOT-0002

Evaluation Criteria

Both lots use the following evaluation criterion:

• Cost: The criteria and their weightings are defined in the consultation rules
• Method: The scoring criteria and their weightings are indicated in the consultation rules

Procurement Analysis

• Procedure: Open procedure under the standard regime, governed by EU Directive 2014/24/EU
• Competition: 10 tenders (LOT-0001); 11 tenders (LOT-0002)
• Subcontracting: Yes for several winners (value and percentage unknown)
• No EU funding: The procurement was not financed with EU funds
• Framework agreement: Framework agreement, with reopening of competition
• No dynamic purchasing system used
• Review body: Tribunal administratif de Nancy
• Call for competition terminated: The call for competition has been terminated (contracts awarded)

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA)
• No EU funds were used for this procurement
• The maximum framework value in this notice is €31,000,000.00
• Lot 1 maximum value is €6,000,000.00; Lot 2 maximum value is €25,000,000.00
• The procurement is divided into two lots
• Cost criteria and weightings are defined in the consultation rules
• 10 tenders (Lot 1) and 11 tenders (Lot 2) were received (submitted electronically)
• Winners include large enterprises and SMEs
• Subcontracting was declared by several winners
• The contract duration is 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• The contracts were concluded on 28 September 2026
• The contract is executed at the scale of the ARS of metropolitan and overseas France

Market & Industry Perspective

The French public sector health evaluation consultancy market features a mix of large international consultancies and specialised SMEs. Evaluation consultancy services are essential for assessing Regional Health Projects and related actions, projects or systems.

Key trends in this market include:

• Cost criteria: Evaluation based on criteria and weightings defined in the consultation rules
• Mix of providers: Large enterprises and SMEs appointed
• Multi-lot structure: Two lots covering PRS evaluation and action/project evaluation
• Long-term frameworks: Up to 48 months including renewals
• National coverage: ARS of metropolitan and overseas France
• Subcontracting: Declared by several winners
• Framework with reopening: Framework agreement with reopening of competition

Economic Significance

At €31,000,000.00 maximum framework value in this notice, this framework represents a significant investment in evaluation consultancy services for the ARS. The contract will:

• Support Public Health Evaluation: Provide evaluation of Regional Health Projects and related actions
• Support Both Large Enterprises and SMEs: Winners include large enterprises and SMEs
• Provide Long-Term Stability: Framework running up to 48 months including renewals
• Ensure Service Availability: Multi-supplier framework across two lots
• Enable National Coverage: ARS of metropolitan and overseas France
• Support Evidence-Based Health Policy: Evaluation of actions, projects and systems

Future Procurement Opportunities

With this framework now in place, future opportunities include:

• Re-tender: Expected after the maximum 48-month duration
• Related Services: Additional evaluation consultancy services
• Subcontracting: Potential opportunities with framework winners
• Other ARS Projects: Similar evaluation consultancy procurement opportunities
• Renewals: Tacit renewals may create further opportunities

Opportunities for Suppliers

While this contract is awarded, opportunities remain for evaluation consultancy service providers:

• Re-tender: Prepare for future procurement cycles
• Subcontracting: Potential opportunities with framework winners
• Related Services: Other evaluation consultancy services
• Other ARS Projects: Similar evaluation consultancy procurements
• Renewals: Monitor renewal opportunities

What Businesses Should Watch

• ARS Grand-Est's future procurement notices
• Other French ARS evaluation consultancy tenders
• Evaluation consultancy market trends
• Changes to French procurement regulations
• Regional Health Project evaluation requirements
• Renewal option decisions

FranceTenders.com Procurement Intelligence

This inter-ARS evaluation framework is a notable example of French public sector procurement. Several features stand out:

• Scale: €31M maximum framework value in this notice (Lot 1 €6M; Lot 2 €25M)
• Cost criteria: Evaluation based on criteria and weightings defined in the consultation rules
• Mix of winners: Large enterprises and SMEs across six groupements
• Two lots: PRS evaluation (Lot 1) and action/project/system evaluation (Lot 2)
• Competition: 10 tenders (Lot 1); 11 tenders (Lot 2)
• Long-term framework: 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• National coverage: ARS of metropolitan and overseas France
• Subcontracting: Declared by several winners

For suppliers, this procurement highlights the importance of:

• Cost: Evaluation based on criteria and weightings defined in the consultation rules
• Evaluation consultancy expertise: Ability to deliver evaluation of health projects, actions and systems
• Public sector experience: Understanding of French ARS requirements
• Scale capability: Ability to serve metropolitan and overseas France
• Framework awareness: Understanding of frameworks with reopening of competition
• Subcontracting capability: Ability to work with subcontractors where relevant

Supplier Takeaways

• Offer competitive cost – evaluation based on criteria and weightings defined in the consultation rules
• Demonstrate evaluation consultancy expertise for health projects and systems
• Develop public sector experience with French ARS
• Demonstrate scale capability for national coverage
• Showcase framework awareness for frameworks with reopening of competition
• Monitor ARS Grand-Est and French ARS procurement opportunities
• Prepare for subcontracting opportunities with framework winners

Key Takeaways

• ARS Grand-Est awarded a €31,000,000.00 inter-ARS evaluation framework for Regional Health Projects
• Two lots: LOT-0001 (Evaluation of the Regional Health Project of each ARS, €6M) and LOT-0002 (Evaluation of actions, projects or systems, €25M)
• Duration: 12 months, with tacit renewal three times for 12 months (maximum 48 months)
• Evaluation: Cost criteria and weightings defined in the consultation rules
• 10 tenders (Lot 1); 11 tenders (Lot 2)
• Winners (Lot 1): Groupement CAPGEMINI x KPMG; Groupement TECHNOPOLIS x SEDETIAM x PLURICITE x HIPPOCRATE DEVELOPPEMENT; Groupement PWC x FORVIS MAZARS
• Winners (Lot 2): Groupement ACSANTIS x SCET x ADOPALE; Groupement PLANETE PUBLIQUE x Agence PHARE; Groupement KPMG x CAPGEMINI
• Winners include large enterprises and SMEs
• Subcontracting declared by several winners
• No EU funding
• Covered by GPA: Yes
• Framework with reopening of competition
• Contract executed at the scale of the ARS of metropolitan and overseas France
• Contracts concluded on 28 September 2026

Conclusion

This inter-ARS evaluation framework ensures that the ARS have access to a broad panel of qualified evaluation consultancy service providers for the evaluation of their Regional Health Projects and related actions, projects or systems. By awarding the framework across two lots to six groupements, ARS Grand-Est secures a diverse panel with the capability to deliver evaluation consultancy services at the scale of metropolitan and overseas France.

The cost-based evaluation (criteria and weightings defined in the consultation rules) reflects the balanced nature of evaluation consultancy procurement, where cost and quality are important differentiators among qualified suppliers. The two-lot structure, the tacit renewals and the national coverage reflect the specific operational and strategic context of the French ARS health evaluation needs.

For suppliers, this procurement highlights the importance of cost, evaluation consultancy expertise, public sector experience, scale capability, framework awareness and subcontracting capability in winning French public sector health evaluation contracts.

Frequently Asked Questions

Q: What is ARS Grand-Est?

Ans: A body governed by public law operating in the health sector in France, the Regional Health Agency for the Grand-Est region.

Q: What is the value of the framework?

Ans: Maximum framework value in this notice €31,000,000.00 (Lot 1 €6,000,000.00; Lot 2 €25,000,000.00).

Q: Who are the winners?

Ans: Lot 1: Groupement CAPGEMINI x KPMG; Groupement TECHNOPOLIS x SEDETIAM x PLURICITE x HIPPOCRATE DEVELOPPEMENT; Groupement PWC x FORVIS MAZARS. Lot 2: Groupement ACSANTIS x SCET x ADOPALE; Groupement PLANETE PUBLIQUE x Agence PHARE; Groupement KPMG x CAPGEMINI.

Q: What services are covered?

Ans: Evaluation consultancy services, including evaluation of the Regional Health Project of each ARS (Lot 1) and evaluation of actions, projects or systems implemented within the framework of the Regional Health Project (Lot 2).

Q: What were the evaluation criteria?

Ans: Cost criteria and weightings defined in the consultation rules.

Q: How long is the contract?

Ans: 12 months, with tacit renewal three times for 12 months, up to a maximum total duration of 48 months.

Q: How many tenders were received?

Ans: 10 tenders (Lot 1); 11 tenders (Lot 2).

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Q: What is the review body?

Ans: Tribunal administratif de Nancy.

Q: What is the lot structure?

Ans: Two lots – LOT-0001 (Evaluation of the Regional Health Project of each ARS) and LOT-0002 (Evaluation of actions, projects or systems implemented within the framework of the Regional Health Project).

Q: Is subcontracting allowed?

Ans: Yes, subcontracting was declared by several winners (value and percentage unknown).

Q: What is the geographic scope?

Ans: The contract is executed at the scale of the ARS of metropolitan and overseas France.

Q: How many renewals are possible?

Ans: Maximum of 3 renewals of 12 months each, up to a maximum total duration of 48 months.

Source: EU Official Journal, Contract Award Notice 673914-2026, OJ S 189/2026, published 30 September 2026.

```